Guliz Ozgun

This study is testing whether the time of day when standard immunotherapy drugs are given affects how well they work for adults with advanced kidney cancer. Researchers will compare giving the treatment in the morning versus the afternoon to see if timing impacts survival, side e…

This study investigates whether giving standard bladder cancer drugs in the morning versus the afternoon affects how well they work and their side effects. Researchers will enroll 224 adults with advanced bladder cancer and randomly assign them to receive their infusions either b…